FindTrial
Sign In

A study to check if a skin care product is safe and helps reduce signs of ageing

To evaluate the safety and efficacy of a Skin care formulation in terms of antiaging reduction in fine lines and wrinkles, reduction in pigmentary patches, skin firmness, skin homogeneity and skin moisturisation on healthy human subjects. - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098921
Enrollment
36
Registered
2025-12-11
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: VLCLBOTOFLESRM628: The Product is applied on Whole face two times in a day for the period of 84 days. Control Intervention1: Nil: NA

Sponsors

VLCC Personal Care Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Indian male and Female subjects 2)Healthy subjects 3)Skin is healthy on the studied anatomic unit 4)Having crows feet, under eye, forehead and nasolabial wrinkles and fine lines, having dull skin, having dark spots and patchy skin

Exclusion criteria

Exclusion criteria: 1)For Females: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months. 2)Having refused to give his/her assent by not signing the consent form 3)Taking part in another study liable to interfere with this study 4)Being insulin-dependent diabetic or non-insulin-dependent diabetic with a recent therapy (less than 6 months) 5)Having acne prone skin. 6)Having non stabilized thyroid problems (requirement of a stabilized treatment for at least 6 months) 7)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products. 8)Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, antihistamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol). 9)Having cutaneous hypersensitivity. 10)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months. 11)Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit. 12)Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)

Design outcomes

Primary

MeasureTime frame
Reduction in fine lines and wrinkles, reduction in pigmentary patches, skin firmness, skin homogeneity and skin moisturisationTimepoint: Baseline, Day 14, Day28, Day 42, Day56, Day 70 and Day 84—

Secondary

MeasureTime frame
NilTimepoint: NA—

Countries

India

Contacts

Public ContactDr Mohit Lalvani

MASCOT-SPINCONTROL India Pvt. Ltd.

niharika@mascotspincontrol.in02243349191

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026